TGF-β may act as a tumour suppressor in the early stages of tumourigenesis, but it functions as a protooncogene at later tumour stages by stimulating angiogenesis and inducing EMT for tumour cell invasion and metastasis. The gene discussed is TGFB1; the disease is neoplasm.